SE0102858D0 - N-type calcium channel antagonists for the treatment of pain - Google Patents
N-type calcium channel antagonists for the treatment of painInfo
- Publication number
- SE0102858D0 SE0102858D0 SE0102858A SE0102858A SE0102858D0 SE 0102858 D0 SE0102858 D0 SE 0102858D0 SE 0102858 A SE0102858 A SE 0102858A SE 0102858 A SE0102858 A SE 0102858A SE 0102858 D0 SE0102858 D0 SE 0102858D0
- Authority
- SE
- Sweden
- Prior art keywords
- sup
- treatment
- pain
- calcium channel
- type calcium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0102858A SE0102858D0 (sv) | 2001-08-27 | 2001-08-27 | N-type calcium channel antagonists for the treatment of pain |
PCT/SE2002/001521 WO2003018561A1 (en) | 2001-08-27 | 2002-08-23 | N-type calcium channel antagonists for the treatment of pain |
AT02760975T ATE295837T1 (de) | 2001-08-27 | 2002-08-23 | Antagonisten für calciumkanäle vom n-typ zur behandlung von schmerzen |
JP2003523224A JP2005508894A (ja) | 2001-08-27 | 2002-08-23 | 痛みの治療のためのn型カルシウムチャネルアンタゴニスト |
EP02760975A EP1430030B1 (en) | 2001-08-27 | 2002-08-23 | N-type calcium channel antagonists for the treatment of pain |
US10/488,025 US7153865B2 (en) | 2001-08-27 | 2002-08-23 | N-type calcium channel antagonists for the treatment of pain |
DE60204232T DE60204232T2 (de) | 2001-08-27 | 2002-08-23 | Antagonisten für calciumkanäle vom n-typ zur behandlung von schmerzen |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0102858A SE0102858D0 (sv) | 2001-08-27 | 2001-08-27 | N-type calcium channel antagonists for the treatment of pain |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0102858D0 true SE0102858D0 (sv) | 2001-08-27 |
Family
ID=20285150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0102858A SE0102858D0 (sv) | 2001-08-27 | 2001-08-27 | N-type calcium channel antagonists for the treatment of pain |
Country Status (7)
Country | Link |
---|---|
US (1) | US7153865B2 (sv) |
EP (1) | EP1430030B1 (sv) |
JP (1) | JP2005508894A (sv) |
AT (1) | ATE295837T1 (sv) |
DE (1) | DE60204232T2 (sv) |
SE (1) | SE0102858D0 (sv) |
WO (1) | WO2003018561A1 (sv) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002361846A1 (en) * | 2001-12-21 | 2003-07-15 | Bayer Pharmaceuticals Corporation | Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents |
US7223754B2 (en) | 2003-03-10 | 2007-05-29 | Dynogen Pharmaceuticals, Inc. | Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disorders |
US7084116B2 (en) | 2003-03-10 | 2006-08-01 | Dynogen Pharmaceuticals, Inc. | Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using Cav2.2 subunit calcium channel modulators |
MXPA05009722A (es) * | 2003-03-10 | 2006-03-09 | Schering Corp | Inhibidores heterociclicos de cinasa: metodos de uso y sintesis. |
WO2005000285A2 (en) * | 2003-06-13 | 2005-01-06 | Dynogen Pharmaceuticals, Inc. | METHODS OF TREATING NON-INFLAMMATORY GASTROINTESTINAL TRACT DISORDERS USING Cav2.2 SUBUNIT CALCIUM CHANNEL MODULATORS |
US20060128702A1 (en) * | 2004-11-23 | 2006-06-15 | Manojit Pal | Heterocyclic and bicyclic compounds, compositions and methods |
AU2006329040C1 (en) | 2005-12-22 | 2011-12-08 | Newron Pharmaceuticals S.P.A. | 2 -Phenylethylamino derivatives as calcium and/or sodium channel modulators |
CN101687773B (zh) | 2007-06-15 | 2014-07-30 | 纽朗制药有限公司 | 取代的2-[2-(苯基)乙氨基]烷酰胺衍生物及其作为钠和/或钙通道调节剂的应用 |
US8987301B2 (en) | 2009-11-07 | 2015-03-24 | Merck Patent Gmbh | Heteroarylaminoquinolines as TGF-beta receptor kinase inhibitors |
ME02524B (me) | 2011-06-27 | 2017-02-20 | Newron Pharm Spa | Fluorisani derivati arilalkilaminokarboksamida |
EP3632426A1 (en) | 2013-02-01 | 2020-04-08 | Wellstat Therapeutics Corporation | Amine compounds having anti-inflammatory, antifungal, antiparasitic and anticancer activity |
CN105407894A (zh) | 2013-03-14 | 2016-03-16 | 康威基内有限公司 | 用于抑制含布罗莫结构域的蛋白质的方法和组合物 |
ES2918589T3 (es) | 2015-11-25 | 2022-07-19 | Convergene Llc | Inhibidores de bromodomios BET bicíclicos y usos de los mismos |
WO2019045655A1 (en) * | 2017-08-29 | 2019-03-07 | Chulabhorn Foundation | DERIVATIVES AND COMPOSITION OF QUINOLINE AND NAPHTHYRIDINE |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1573186A (en) * | 1977-09-14 | 1980-08-20 | Wyeth John & Brother Ltd | 4-aminoquinoline derivatives |
AU4802500A (en) * | 1999-04-26 | 2000-11-10 | Neurogen Corporation | 2-aminoquinolinecarboxamides: neurokinin receptor ligands |
-
2001
- 2001-08-27 SE SE0102858A patent/SE0102858D0/sv unknown
-
2002
- 2002-08-23 US US10/488,025 patent/US7153865B2/en not_active Expired - Fee Related
- 2002-08-23 AT AT02760975T patent/ATE295837T1/de not_active IP Right Cessation
- 2002-08-23 JP JP2003523224A patent/JP2005508894A/ja active Pending
- 2002-08-23 DE DE60204232T patent/DE60204232T2/de not_active Expired - Fee Related
- 2002-08-23 WO PCT/SE2002/001521 patent/WO2003018561A1/en active IP Right Grant
- 2002-08-23 EP EP02760975A patent/EP1430030B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20050131020A1 (en) | 2005-06-16 |
JP2005508894A (ja) | 2005-04-07 |
WO2003018561A1 (en) | 2003-03-06 |
EP1430030A1 (en) | 2004-06-23 |
US7153865B2 (en) | 2006-12-26 |
DE60204232D1 (de) | 2005-06-23 |
ATE295837T1 (de) | 2005-06-15 |
DE60204232T2 (de) | 2006-01-26 |
EP1430030B1 (en) | 2005-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0004053D0 (sv) | N-type calcium channel antagonists for the treatment of pain | |
EA200401169A1 (ru) | Аминометилзамещенные тетрациклиновые соединения | |
NO20026064D0 (no) | Nye forbindelser | |
SE9504661D0 (sv) | New compounds | |
DE60334379D1 (de) | Copolymerverbindung, diese enthaltende polymerzusammensetzung, bilderzeugungsverfahren und dieselbe benutzende bilderzeugungsvorrichtung | |
ATE365703T1 (de) | Substituierte 1,3-diphenylprop-2-en-1-on derivate,deren herstellung und anwendungen | |
PT1157037E (pt) | Conjugados de gcsf | |
SE0102858D0 (sv) | N-type calcium channel antagonists for the treatment of pain | |
SE9802729D0 (sv) | Novel Compounds | |
SE0302139D0 (sv) | Novel compounds | |
SE0004054D0 (sv) | N-type calcium channel antagonists for the treatment of pain | |
SE9802208D0 (sv) | Novel compounds | |
YU13301A (sh) | Muskarinski agonisti i antagonisti | |
AR021695A1 (es) | 4,5-pirazinoxindoles, composicion farmaceutica y uso | |
SE0003476D0 (sv) | Compounds | |
SE0101038D0 (sv) | Novel compounds | |
SE0301320D0 (sv) | Positive modulators of nicotinic acetylcholine receptors | |
SE0203070D0 (en) | Novel compounds | |
DE50310579D1 (de) | Furancarboxamide | |
DK1532131T3 (da) | Motilid-forbindelser | |
SE0303280D0 (sv) | Novel compounds | |
SE0203300D0 (sv) | Novel Compounds | |
SE0302755D0 (sv) | Novel compounds | |
DE50311756D1 (de) | Mikrobizide oxathiincarboxamide | |
SE0004055D0 (sv) | N-type calcium channel antagonists for the treatment of pain |